In 2015, former President Obama announced to launch the Precision Medicine Initiative — a bold new personalized medicine to revolutionize how we improve health and treat disease. He also announced a national moonshot initiative to eliminate cancer in 2016. These powerful announcements are aimed not only to treat cancer, but also to emphasize the prevention of cancer as well as the integrated medicine.
The core value of precise medicine is “an emerging approach for disease treatment and prevention that takes into account individual variability in genes, environment, and lifestyle for each person." In the past, doctors usually approached disease treatment and prevention strategies for the average person by the way of “one-size-fits-all”, with less consideration for the differences between individuals. It is in contrast to the precise medicine, which allows doctors and researchers to predict more accurate treatment and prevention strategies for a particular disease working in which groups of people.
So far, the precise medicine provided by each domestic biotech company is limited to the operation of the next-generation sequencing (NGS) and the analysis of bioinformatics. However, there are no clinical reports signed by the responsible doctor as well as no consultant services for patients to dispel their doubts. KimForest, fortunately, is constructing the only “integrated precise medicine” in Taiwan. We provide accurate genetic testing, professional analysis, comprehensive reports, and reliable consultants. KimForest can help with support through every stage of treatment with providing more dependable service, and lower maintenance time and costs.